Predicting Response and Exposure Changes in Cirrhosis for Effectiveness
NCT07750587
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Liver Cirrhosis
Interventions
DRUG:
Five-Drug CYP Probe Cocktail
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)